Novartis CEO Says It's `Prudent' to Pull Back From Further Price Increases
2,299 views · Published 18 July 2018 · 6:18 · Indexed 25 October 2026
Channel: Bloomberg Television · 2018 · News & Politics
Jul.18 -- Novartis AG Chief Executive Officer Vas Narasimhan talks about U.S. drug pricing, government health-care policy and plans to spin off the Swiss drugmaker's Alcon eye-care unit. He speaks from Basel, Switzerland, on "Bloomberg Daybreak: Europe" after profit beat estimates in the second quarter, allowing Novartis to reiterate its full-year forecast.
More from this channel
-
2:16
Economic Policy Institute's Bivens Says Criticism of Tariffs Is Warranted
-
3:02
Blanchflower Says Raising Rates 'Is a Fundamental Mistake'
-
2:57
BlackRock's Rieder Says It's a Risk-Off Environment
-
2:04
How Weather Impacted U.S. Job Creation in March
-
2:32
Millennials Are Finding Jobs, Just Not the Ones They Want
-
1:06
Powell Says Gradual Rate Hikes Best Promote the Fed's Goals
-
0:58
Powell Says Wage Growth Shows Job Market Not 'Excessively Tight'
-
2:17
Quad Capital's Borish Sees More Whiplash in Markets